GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 371 filers reported holding GLOBUS MED INC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $546,575 | +7.5% | 11,010 | +28.9% | 0.00% | 0.0% |
| Q2 2023 | $508,462 | -7.2% | 8,539 | -11.7% | 0.00% | 0.0% |
| Q1 2023 | $548,057 | -86.5% | 9,666 | -82.3% | 0.00% | -87.5% |
| Q4 2022 | $4,057,135 | +46.7% | 54,635 | +17.6% | 0.01% | +33.3% |
| Q3 2022 | $2,766,000 | +3.8% | 46,459 | -2.1% | 0.01% | 0.0% |
| Q2 2022 | $2,666,000 | +74.4% | 47,470 | +115.1% | 0.01% | +100.0% |
| Q1 2022 | $1,529,000 | -4.4% | 22,070 | -0.3% | 0.00% | 0.0% |
| Q4 2021 | $1,599,000 | +17.1% | 22,126 | +24.6% | 0.00% | 0.0% |
| Q3 2021 | $1,365,000 | +18.4% | 17,757 | +19.5% | 0.00% | +50.0% |
| Q2 2021 | $1,153,000 | +36.1% | 14,855 | +8.3% | 0.00% | 0.0% |
| Q1 2021 | $847,000 | +4.6% | 13,719 | +10.4% | 0.00% | 0.0% |
| Q4 2020 | $810,000 | +77.6% | 12,432 | +35.5% | 0.00% | +100.0% |
| Q3 2020 | $456,000 | +13.7% | 9,175 | +8.9% | 0.00% | 0.0% |
| Q2 2020 | $401,000 | +78.2% | 8,424 | +59.4% | 0.00% | 0.0% |
| Q1 2020 | $225,000 | – | 5,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
| Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
| Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
| XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
| Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
| RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
| Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
| Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |